drugset
drugset / Trial / NCT01596010

Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women

NCT01596010 ↗

Phase 1 Completed 44 enrolled Novo Nordisk A/S
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to investigate whether a reformulated estradiol/norethisterone acetate (NETA) formulation is bioequivalent to that of Kliogest® (estradiol/norethisterone acetate (NETA) in healthy women.

Timeline

Start
2007-10
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 2 mg Oral
Subject Norethindrone Unknown 1 mg Oral

Indications

No indication recorded.